TCRT · Alaunos Therapeutics Inc
United States · RS rating 45 · As of 2026-11-03
| Price | 1.86 USD |
|---|---|
| 1-day change | +6.3% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 99 / 50 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 29 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +30.5% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +57.3% |
| Market cap (USD) | $6.6M |